Sherwin-Williams Company
Thesis
Sherwin-Williams has compounded at approximately 22% since the recovery of 2009 and around 15.5% over the past thirty years. The company boasts high returns on invested capital of 30% or better and has a strong distribution system, making it a compelling long-term investment.
Did it work?
The pitch is a general long-term quality-compounder thesis on Sherwin-Williams, citing historical ~15.5-22% compounding and 30%+ ROIC, but it includes no stated price target, horizon, or specific catalyst to verify. With no time elapsed and no price performance data available, there is no way to assess whether the forward-looking claim of continued compelling returns has played out. The historical facts cited were true at the time of the pitch, but the investment outcome itself cannot be judged.